Lissy de Ridder, Dan Turner, David C Wilson, Sibylle Koletzko, Javier Martin-de-Carpi, Ulrika L Fagerberg, Christine Spray, Malgorzata Sladek, Ron Shaoul, Eleftheria Roma-Giannikou, Jiri Bronsky, Daniela E Serban, Salvatore Cucchiara, Gabor Veres, Frank M Ruemmele, Iva Hojsak, Kaija L Kolho, Ieuan H Davies, Marina Aloi, Paolo Lionetti, Gigi Veereman-Wauters, Christian P Braegger, Eunice Trindade, Anne V Wewer, Almuthe Hauer, Arie Levine
BACKGROUND: The combination of the severity of pediatric-onset inflammatory bowel disease (IBD) phenotypes and the need for intense medical treatment may increase the risk of malignancy and mortality, but evidence regarding the extent of the problem is scarce. Therefore, the Porto Pediatric IBD working group of ESPGHAN conducted a multinational-based survey of cancer and mortality in pediatric IBD. METHODS: A survey among pediatric gastroenterologists of 20 European countries and Israel on cancer and/or mortality in the pediatric patient population with IBD was undertaken...
February 2014: Inflammatory Bowel Diseases